MEF2D-APOA2 Fusion FISH Probe
The MEF2D-APOA2 Fusion FISH Probe is used to confirm a fusion of the MEF2D and APOA2 genes. The fusion of the MEF2D and APOA2 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MEF2D-APOA2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MEF2D-APOA2-20-AQAQ | 20 (40 μL) | 200 μL |
|
APOA2 Gene Summary
This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia. [provided by RefSeq, Jul 2008]
Gene Name: Apolipoprotein A2
Chromosome: CHR1: 161192082 -161193418
Locus: 1q23.3
MEF2D Gene Summary
This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
Gene Name: Myocyte Enhancer Factor 2D
Chromosome: CHR1: 156433518 -156470529
Locus: 1q22
Gene Diseases
The MEF2D APOA2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|